Miami Cancer Institute and Eugene M. and Christine E. Lynn Cancer Institute to Present Latest Research at 2024 Annual Meeting of the American Society for Radiation Oncology
MIAMI, FL & SAN DIEGO, CA – August 30, 2024 – Miami Cancer Institute and Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health Cancer Care, today announced their oral and poster presentations as well as educational sessions at the American Society for Radiation Oncology (ASTRO) Annual Meeting. Taking place September 29 – October 2, 2024 at the Walter E. Washington Convention Center in Washington, D.C., the presentations will focus on the latest treatment approaches to head and neck, lung, pancreatic, and prostate cancer as well as brain tumors and metastases.
“I could not be more pleased with the quality of the research my colleagues and I will be presenting at this year’s ASTRO annual meeting,” said Minesh P. Mehta, M.D., deputy director and chief of radiation oncology with Miami Cancer Institute. “The research presented on behalf of both cancer institutes within Baptist Health South Florida represents areas of great unmet medical need. The themes represented by our research presentations focus on several cutting-edge technologies in radiation oncology, with several presentations showcasing very important clinical results. These presentations therefore underscore our unified forward-looking mission to provide the best possible care to cancer patients.”
Miami Cancer Institute and Lynn Cancer Institute researchers will have three oral and six poster presentations, and host four educational sessions at ASTRO 2024:
Oral Presentation
Sunday, September 29, 2024
Exploring the Future of AI, Radiomics, and Deep Learning in Radiation Oncology Research
Moderator: Hina Saeed, M.D.
Time: 04:45 p.m. – 06:00 p.m. ET
Location: Room 207 B
Tuesday, October 1, 2024
Phase 2 Trial of Stereotactic MR-Guided Adaptive Radiation Therapy in One Fraction (SMART ONE)
Speaker: Michael Chuong, M.D.
Time: 08:00 a.m. – 08:10 a.m. ET
Location: Room 140
Wednesday, October 2, 2024
Multi-Institutional Comparison of Ablative 5-Fraction MR-Guided Online Adapted vs. 15/25-Fraction CT-Guided Offline Adapted Radiation Therapy for Locally Advanced Pancreas Cancer
Speaker: Michael Chuong, M.D.
Time: 10:30 a.m. – 10:40 a.m. ET
Location: Room 144
Poster Presentations
Sunday, September 29, 2024
Assessing and Quantifying Patient External Contour Changes for Node Positive Dose Escalated Prostate Cancer Using Proton Therapy
Presenter: Marcio Fagundes, M.D.
Time: 4:45 p.m. – 6:00 p.m. ET
Poster #: 2279
Location: Hall C
Monday, September 30, 2024
Ablative Stereotactic MR-Guided Adaptive Radiotherapy in Patients with Infra-Diaphragmatic Oligometastatic Disease
Presenter: Eyub Yasar Akdemir, M.D.
Time: 10:45 a.m. – 12:00 p.m. ET
Poster #: 2479
Location: Hall C
Contrast-Enhancing Lesions Induced by CNS-Directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics and Clinical Outcomes
Presenter: Omer Gal, M.D.
Time: 10:45 a.m. – 12:00 p.m. ET
Poster #: 2515
Location: Hall C
Development of a Machine Learning-Based Tool to Predict Local Failure after Stereotactic Radiosurgery for Small Brain Metastases
Presenter: Sreenija Yarlagadda, M.D.
Time: 10:45 a.m. – 12:00 p.m. ET
Poster #: 2645
Location: Hall C
Impact of Systemic Therapy Selection on Brain Metastasis Outcomes in Lung Cancer Patients Treated with Stereotactic Radiosurgery
Presenter: Rupesh Kotecha, M.D., & Alonso La Rosa, M.D.
Time: 10:45 a.m. – 12:00 p.m. ET
Poster #: 2551
Location: Hall C
Prospective Longitudinal Study of Quality of Life, Brain Substructure Atrophy, and Neurocognitive Outcomes in Children Following Proton Therapy for Brain Tumors
Presenter: Katherine von Werne, MSN
Time: 5:00 p.m. – 6:00 p.m. ET
Poster #: 2898
Location: Hall C
Wednesday, October 2, 2024
Taste Changes in Patients Receiving Head and Neck Radiation – Initial Analysis from a Prospective Study
Presenter: Sreenija Yarlagadda, M.D.
Time: 10:30 a.m. – 11:45 a.m. ET
Poster #: 3762
Location: Hall C
Educational Sessions
Sunday, September 29, 2024
Clinical Rationale for On-Line ART and Rationale for Technologies (MRgRT, CTgRT, BgRT, Protons)
Speaker: Michael Chuong, M.D.
Time: 2:45 p.m. – 2:58 p.m. ET
Location: Room 147
Advances in Brain Reirradiation: Integrating Current Evidence into Everyday Clinical Practice
Speaker: Minesh Mehta, M.D., M.B., Ch.B., FASTRO
Time: 4:59 p.m. – 5:11 p.m. ET
Location: Room 143
Tuesday, October 1, 2024
Quality of Life after Ablative 5-Fraction Radiation Therapy from the Phase 2 SMART Pancreas Trial
Speaker: Michael Chuong, M.D.
Time: 01:35 p.m. – 01:45 p.m. ET
Location: Room 140 (quick pitch)
Wednesday, October 2, 2024
Clinical Data and Dose Evaluation
Moderator: Kathryn Mittauer, Ph.D.
Time: 12:30 p.m. – 01:30 p.m. ET
Location: Room 144
For updates from the ASTRO 2024 Annual Meeting, look for #ASTRO2024 on social media and follow @miamicancerinst, @baptisthealthsf and @baptisthealthcancercare on X (Twitter).
About Baptist Health Cancer Care
Baptist Health Cancer Care is the largest cancer program in South Florida, providing local, out-of-state and international patients with the most advanced cancer care. With locations from the Florida Keys to the Palm Beaches, the program provides cancer patients access to a full array of innovative clinical trials, physicians dedicated to bringing discovery to the bedside, access to personalized cancer treatments and comprehensive patient support services – all delivered with unparalleled compassion. Baptist Health Cancer Care includes its state-of-the-art premier institutes, Baptist Health Miami Cancer Institute and Baptist Health Lynn Cancer Institute, with renowned subspecialized surgical oncologists, medical oncologists and radiation oncologists, and highly advanced technologies available to treat every common and rare cancer.
Baptist Health Cancer Care is part of Baptist Health, based in South Florida, providing care through a network of 12 hospitals as well as more than 150 outpatient facilities and physician practices, welcoming more than 1.5 million patients from around the world each year. Baptist Health Cancer Care is also Florida’s only member of the Memorial Sloan Kettering Cancer Alliance, an alliance based on common standards of care and many shared clinical trials.
To learn more about Baptist Health Cancer Care, visit Baptisthealth.net/cancercare.
###
